ArticleRadiation oncology (London, England)2022

Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.

Karl Wurstbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.